BioCity
Latest round
- Series A
Last raised
- Jul 2024
Total raised
- Undisclosed
Investors
- 3
About BioCity
, trading as BioCity, operates as an innovative pharmaceutical company dedicated to providing innovative drugs for cancer treatment. It has an R&D Center in Shanghai. The founder and chair of the company, Xiangbo Jia, graduated from the Australian National University and has experience in entrepreneurship and investment in the biomedical field. The CEO of the company, Yongjiang Hei, graduated from Columbia University. The company mainly provides BIC/FIC (Best in class/ First in Class) innovative drugs. The product pipeline targets kidney disease and tumors, and is indicated for IgA (Immunoglobulin A) nephropathy, diabetic nephropathy, solid tumors, small cell lung cancer, advanced ovarian cancer, and advanced hepatocellular carcinoma. BioCity also provides a translational medicine platform, which has the functions of predictive biomarker discovery and validation, new target validation, and drug resistance mechanism discovery. The company generates revenue by providing innovative drugs for the treatment of tumors, chronic kidney disease and other diseases, as well as the translational medicine platform.
Who invested in BioCity
3 investors across 1 round
See all investors in BioCity
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 31, 2024
Amount
Undisclosed
Investors
Questions about BioCity
Who invested in BioCity?
BioCity has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioCity raised?
BioCity has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioCity last raise money?
BioCity's most recent round on record is a Series A, in Jul 2024.
What does BioCity do?
, trading as BioCity, operates as an innovative pharmaceutical company dedicated to providing innovative drugs for cancer treatment.
Where is BioCity headquartered?
BioCity is headquartered in Wuxi, China.
Which VCs invest in companies like BioCity?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at BioCity's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like BioCity? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.